OTCMKTS:BETRF BetterLife Pharma (BETRF) Stock Price, News & Analysis $0.13 -0.01 (-10.56%) As of 11:33 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsSEC Filings About BetterLife Pharma Stock (OTCMKTS:BETRF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BetterLife Pharma alerts:Sign Up Key Stats Today's Range$0.13▼$0.1550-Day Range$0.13▼$0.2852-Week Range$0.03▼$0.33Volume67,005 shsAverage Volume94,744 shsMarket Capitalization$21.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BetterLife Pharma Inc. is a Canadian biotechnology company developing drug candidates for mental health and neurological conditions, with a focus on psychedelic-related compounds. Its pipeline includes BETR-001, a non-hallucinogenic LSD derivative being investigated for depression and other neuropsychiatric disorders, and BETR-002, an ibogaine-derived candidate being developed for substance use disorders. BetterLife’s work is focused on research and development; these candidates are investigational and are not approved treatments. The company is based in Canada.AI Generated. May Contain Errors. Read More BetterLife Pharma Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScoreBETRF MarketRank™: 0.27140013271 of 5 starsBetterLife Pharma scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for BetterLife Pharma. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of BetterLife Pharma is -14.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BetterLife Pharma is -14.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.06% of the float of BetterLife Pharma has been sold short.Short Interest Ratio / Days to CoverBetterLife Pharma has a short interest ratio ("days to cover") of 0.31, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BetterLife Pharma has recently decreased by 3.53%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBetterLife Pharma does not currently pay a dividend.Dividend GrowthBetterLife Pharma does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows1 people have added BetterLife Pharma to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BetterLife Pharma insiders have not sold or bought any company stock.Percentage Held by Insiders34.77% of the stock of BetterLife Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions0.01% of the stock of BetterLife Pharma is held by institutions.Read more about BetterLife Pharma's insider trading history. Receive BETRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BETRF Stock News HeadlinesBetterLife Pharma Inc. Announces Appointment of Professor Richard B. Lipton as Co-Chair of its Scientific Advisory BoardOctober 20, 2026 | marketscreener.comMBetterLife Pharma Inc. Announces Appointment of Peter Goadsby as Scientific Advisory Board Co-ChairOctober 15, 2026 | marketscreener.comMThis Could Be the Biggest Monetary Shift in 50 YearsThe U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trades above $4,000 today. That gap means Washington's books show about $11 billion in gold that is actually worth more than $1 trillion. A bill in Congress would require repricing those reserves at market value. More than 60 million Americans qualify to move part of their savings into physical gold, tax-free and penalty-free, according to the 2026 Gold and Silver Guide.November 16 at 1:00 AM | Patriot Gold Group (Ad)BetterLife Pharma Inc.: BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical OperationsOctober 15, 2026 | finanznachrichten.deBetterLife Pharma Inc. meldet Ergebnisse für das zweite Quartal und die sechs Monate bis zum 31. Juli 2026September 30, 2026 | de.marketscreener.comDBetterLife Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2026September 29, 2026 | marketscreener.comMAccionistas de BetterLife Pharma IncSeptember 26, 2026 | mx.investing.comA non-hallucinogenic LSD derivative just attracted US$100 millionSeptember 17, 2026 | msn.comSee More Headlines BETRF Stock Analysis - Frequently Asked Questions How have BETRF shares performed this year? BetterLife Pharma's stock was trading at $0.0323 at the start of the year. Since then, BETRF shares have increased by 336.8% and is now trading at $0.1411. How were BetterLife Pharma's earnings last quarter? BetterLife Pharma Inc. (OTCMKTS:BETRF) announced its quarterly earnings results on Tuesday, September, 29th. The company reported ($0.01) EPS for the quarter. How do I buy shares of BetterLife Pharma? Shares of BETRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings9/29/2026Today11/16/2026Fiscal Year End1/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:BETRF CIK1464165 Webwww.abetterlifepharma.com Phone604-221-0595FaxN/AEmployees7Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.07 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-499.72% Debt Debt-to-Equity RatioN/A Current Ratio0.21 Quick Ratio0.21 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-4.21Miscellaneous Outstanding Shares170,120,000Free Float110,966,000Market Cap$21.47 million OptionableNot Optionable Beta0.26 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:BETRF) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredThis Could Be the Biggest Monetary Shift in 50 YearsThe U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trad...Patriot Gold Group | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BetterLife Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.